[
  {
    "ts": "2025-10-31T18:06:00+00:00",
    "headline": "AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised",
    "summary": "ABBV tops Q3 earnings and revenue estimates, driven by Rinvoq and Skyrizi gains, and lifts its 2025 EPS outlook.",
    "url": "https://finance.yahoo.com/news/abbvie-q3-earnings-sales-beat-180600883.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "d210815a-4ebb-352f-9bab-1ad9b73695ff",
      "content": {
        "id": "d210815a-4ebb-352f-9bab-1ad9b73695ff",
        "contentType": "STORY",
        "title": "AbbVie Q3 Earnings & Sales Beat, 2025 EPS Outlook Raised",
        "description": "",
        "summary": "ABBV tops Q3 earnings and revenue estimates, driven by Rinvoq and Skyrizi gains, and lifts its 2025 EPS outlook.",
        "pubDate": "2025-10-31T18:06:00Z",
        "displayTime": "2025-10-31T18:06:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/OQG3.5Wd9P9R69q2rhm9rA--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pBlncPVBhEXpjxtBDlEOsg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/dbd916198e87314e1ef238f8179e6227.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-q3-earnings-sales-beat-180600883.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/abbvie-q3-earnings-sales-beat-180600883.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "RHHBF"
            },
            {
              "symbol": "RHHBY"
            },
            {
              "symbol": "RHHVF"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T18:00:00+00:00",
    "headline": "Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?",
    "summary": "Black Diamond Therapeutics gears up for Q3 results as investors eye key silevertinib data and additional development plans.",
    "url": "https://finance.yahoo.com/news/buy-hold-sell-bdtx-stock-180000515.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "e8b7569c-932e-3b12-8786-c81ba2816610",
      "content": {
        "id": "e8b7569c-932e-3b12-8786-c81ba2816610",
        "contentType": "STORY",
        "title": "Should You Buy, Hold, or Sell BDTX Stock Ahead of Q3 Earnings?",
        "description": "",
        "summary": "Black Diamond Therapeutics gears up for Q3 results as investors eye key silevertinib data and additional development plans.",
        "pubDate": "2025-10-31T18:00:00Z",
        "displayTime": "2025-10-31T18:00:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/4f278dd92e23382650f269f90b5fb0c9",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/F2U5YD8Wk7dT2wbWDBGXZg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f278dd92e23382650f269f90b5fb0c9.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/565G_.yU2UMQcw4nHig1TQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/4f278dd92e23382650f269f90b5fb0c9.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/buy-hold-sell-bdtx-stock-180000515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/buy-hold-sell-bdtx-stock-180000515.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "BDTX"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T17:52:00+00:00",
    "headline": "Appointment of Yves Decadt as Member of Poxel’s Board of Directors",
    "summary": "LYON, France, October 31, 2025--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today announces the appointment of Yves Decadt as a member of its Board of Directors.",
    "url": "https://finance.yahoo.com/news/appointment-yves-decadt-member-poxel-175200791.html",
    "source": "Business Wire",
    "provider": "yfinance",
    "raw": {
      "id": "498cb2f2-8fc1-39d7-8615-9388497447fb",
      "content": {
        "id": "498cb2f2-8fc1-39d7-8615-9388497447fb",
        "contentType": "STORY",
        "title": "Appointment of Yves Decadt as Member of Poxel’s Board of Directors",
        "description": "",
        "summary": "LYON, France, October 31, 2025--Regulatory News: POXEL SA (Euronext : POXEL - FR0012432516), a clinical stage biopharmaceutical company developing innovative treatments for chronic serious diseases with metabolic pathophysiology, including metabolic dysfunction-associated steatohepatitis (MASH) and rare metabolic disorders, today announces the appointment of Yves Decadt as a member of its Board of Directors.",
        "pubDate": "2025-10-31T17:52:00Z",
        "displayTime": "2025-10-31T17:52:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/business-wire.com/f90d435525310fb1141afb468763f2ef",
          "originalWidth": 480,
          "originalHeight": 256,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/PnvwKbjwjmpJ.jPMM5a5JA--~B/aD0yNTY7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f90d435525310fb1141afb468763f2ef.cf.webp",
              "width": 480,
              "height": 256,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/0hjyr0hKLq90TfbHc71mpg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/f90d435525310fb1141afb468763f2ef.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Business Wire",
          "url": "http://www.businesswire.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/appointment-yves-decadt-member-poxel-175200791.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/appointment-yves-decadt-member-poxel-175200791.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "POXEL.PA"
            },
            {
              "symbol": "PXXLF"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T16:30:00+00:00",
    "headline": "I’m 65, itching to retire but only have $500K saved. I want $2K/month plus my Social Security — how can I swing this?",
    "summary": "Here are four options for supplementing your retirement.",
    "url": "https://finance.yahoo.com/news/m-65-itching-retire-only-163000361.html",
    "source": "Moneywise",
    "provider": "yfinance",
    "raw": {
      "id": "fd74dd9d-7676-375c-864d-416d1ca9753d",
      "content": {
        "id": "fd74dd9d-7676-375c-864d-416d1ca9753d",
        "contentType": "STORY",
        "title": "I’m 65, itching to retire but only have $500K saved. I want $2K/month plus my Social Security — how can I swing this?",
        "description": "",
        "summary": "Here are four options for supplementing your retirement.",
        "pubDate": "2025-10-31T16:30:00Z",
        "displayTime": "2025-10-31T16:30:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/moneywise_327/180f805b165fe38dab432b5a25bebabd",
          "originalWidth": 728,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/hRNHmGtXsBV2z5DF32XtPA--~B/aD00MDA7dz03Mjg7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_327/180f805b165fe38dab432b5a25bebabd.cf.webp",
              "width": 728,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/MzWoEe16sAaEqZcTNNmIjw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/moneywise_327/180f805b165fe38dab432b5a25bebabd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Moneywise",
          "url": "https://moneywise.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/m-65-itching-retire-only-163000361.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/m-65-itching-retire-only-163000361.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "KO"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "FG"
            },
            {
              "symbol": "SDR.L"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T14:46:00+00:00",
    "headline": "AbbVie Beats Third-Quarter Estimates. There’s More to the Drugmaker’s Earnings.",
    "summary": "AbbVie  stock dropped Friday after the biopharmaceutical company reported mixed results across its drug portfolios in the third quarter.  Shares declined 4.7% to $217.50, putting AbbVie on pace for its lowest same-day percentage decrease since May 14, according to Dow Jones Market Data.  Pharma peers traded mixed: Johnson & Johnson fell slightly while Pfizer gained 0.7%.",
    "url": "https://www.barrons.com/articles/abbvie-earnings-stock-price-15008c13?siteid=yhoof2&yptr=yahoo",
    "source": "Barrons.com",
    "provider": "yfinance",
    "raw": {
      "id": "1b4fb55c-0c72-3999-8f43-ebf72aff93f1",
      "content": {
        "id": "1b4fb55c-0c72-3999-8f43-ebf72aff93f1",
        "contentType": "STORY",
        "title": "AbbVie Beats Third-Quarter Estimates. There’s More to the Drugmaker’s Earnings.",
        "description": "",
        "summary": "AbbVie  stock dropped Friday after the biopharmaceutical company reported mixed results across its drug portfolios in the third quarter.  Shares declined 4.7% to $217.50, putting AbbVie on pace for its lowest same-day percentage decrease since May 14, according to Dow Jones Market Data.  Pharma peers traded mixed: Johnson & Johnson fell slightly while Pfizer gained 0.7%.",
        "pubDate": "2025-10-31T14:46:00Z",
        "displayTime": "2025-10-31T14:46:00Z",
        "isHosted": false,
        "bypassModal": false,
        "previewUrl": "https://finance.yahoo.com/m/1b4fb55c-0c72-3999-8f43-ebf72aff93f1/abbvie-beats-third-quarter.html",
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd",
          "originalWidth": 1280,
          "originalHeight": 640,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/AUMQE6rlIPt4dCGUiOs_Xw--~B/aD02NDA7dz0xMjgwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd.cf.webp",
              "width": 1280,
              "height": 640,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Sc5SyCgfIAZl0d2DyWRqwQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/Barrons.com/e0e73cec6711c9af8fc0c919cc1ffadd.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Barrons.com",
          "url": "http://www.barrons.com/"
        },
        "canonicalUrl": {
          "url": "https://www.barrons.com/articles/abbvie-earnings-stock-price-15008c13?siteid=yhoof2&yptr=yahoo",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": null,
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "ABBV"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PFE"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2025-10-31T07:49:00+00:00",
    "headline": "The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage",
    "summary": "Broadcom, Johnson & Johnson, and Palantir headline Zacks' latest analyst picks, with AI growth, pharma innovation, and defense tech momentum driving their outlooks.",
    "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-broadcom-074900916.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "3774f9fb-ba32-34e8-b900-0c36a77a0840",
      "content": {
        "id": "3774f9fb-ba32-34e8-b900-0c36a77a0840",
        "contentType": "STORY",
        "title": "The Zacks Analyst Blog Highlights Broadcom, Johnson & Johnson, Palantir Technologies, Fossil Group and Moving iMage",
        "description": "",
        "summary": "Broadcom, Johnson & Johnson, and Palantir headline Zacks' latest analyst picks, with AI growth, pharma innovation, and defense tech momentum driving their outlooks.",
        "pubDate": "2025-10-31T07:49:00Z",
        "displayTime": "2025-10-31T07:49:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/tugIemz.T.iquqxVIoxpHw--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/SHyaOdZAc4DXCya2O4.DtQ--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/74bab520128f201c7e6cc3f67385e761.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-broadcom-074900916.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/zacks-analyst-blog-highlights-broadcom-074900916.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "AVGO"
            },
            {
              "symbol": "JNJ"
            },
            {
              "symbol": "PLTR"
            },
            {
              "symbol": "FOSL"
            },
            {
              "symbol": "MITQ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]